David C. Chin, MD, MBA

Distinguished Scholar
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD

Dr. David C. Chin is a Distinguished Scholar at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine. His focus is preparing health systems and academic medical centers for success under value-based health care and includes novel industry/academic, population HIT, and research partnerships. Before joining Hopkins, he was a senior national partner in the US Healthcare Industries Advisory Practice of PwC and leader of PwC’s Academic Medical Center Practice and Global Healthcare Research Institute. During his career at PwC, Dr. Chin led major strategic planning engagements across the tri-partite mission for health systems, academic medical centers, and universities around the world. He also led the development and dissemination of health care thought leadership for PwC across payer, provider, and pharma life science sectors. Dr. Chin is also the immediate past Chairman and current member of the Board of Directors for the National Committee for Quality Assurance in Washington, DC. Before joining PwC, David was the President of the Novalis Corporation, a privately held company that franchised HMOs on a turnkey basis, and also served on the Board of Directors of Baxter International, Inc. Prior to those positions, he was the President and Medical Director of the Health Centers Division of the Harvard Community Health Plan, a staff model HMO providing health care to residents in Eastern Massachusetts. David holds a BA from Harvard College, an MD from Harvard Medical School, and an MBA from Stanford Business School, as a Robert Wood Johnson Clinical Scholar.

Presentation(s):

• How PM&R Physicians Demonstrate their Value to the C-Suite

  Thursday, October 20, 2022
  3:30 PM – 4:45 PM ET

  Disclosure information not submitted.